Novel Insights from Clinical Practice

Yendo T.M. · Gabbi T.V.B. · Nico M.M.S.

Author affiliations

Department of Dermatology, Medical School, University of São Paulo, São Paulo, Brazil

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: November 15, 2022
Accepted: January 22, 2023
Published online: February 15, 2023

Number of Print Pages: 3
Number of Figures: 1
Number of Tables: 0

ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)

For additional information: https://www.karger.com/SAD

Abstract

Introduction: Discoid lupus erythematosus can affect periungual tissues leading to onychodystrophy. Squamous cell carcinoma can occur in persistent scars of discoid lupus; this rare occurrence has not yet been reported on the nail unit. Case presentation: we report a case of squamous cell carcinoma occurring on the distal phalanx of the thumb in a patient with longstanding periungual discoid lupus on several fingernails. Discussion: Periungual discoid lupus erythematosus is rare. The scars caused by this disease can very rarely develop into squamous cell carcinoma. This is the first report of this occurrence at the periungual tissues.

© 2023 S. Karger AG, Basel

References Trüeb RM. Involvement of scalp and nails in lupus erythematosus. Lupus. 2010 Aug;19(9):1078–86. Wagner C, Chasset F, Francès C, Lipsker D. Lupus érythémateux et atteinte unguéale : étude rétrospective sur 14 patients [Ungual lesions in lupus erythematosus: a retrospective study of 14 patients]. Ann Dermatol Venereol. 2020 Dec;147(12):823–32. Wagner C, Chasset F, Fabacher T, Lipsker D. Lupus érythémateux et atteinte unguéale: revue de la littérature [Ungual lesions in lupus erythematosus: a literature review]. Ann de Dermatologie de Venereologie. 2020 Jan;147(1):18–28. Mufti A, Sachdeva M, Maliyar K, Sibbald RG. Squamous cell carcinoma arising within discoid lupus erythematous lesions: a systematic review. JAAD Int. 2021;2(2):1–4. Ju T, Ingrasci G, Diaz-Perez JA, Obayomi A, Yosipovitch G. Development of squamous cell carcinoma in the setting of chronic discoid lupus erythematosus may be associated with plasmacytoid dendritic cell inflammation. J Cutan Pathol. 2022 Aug 3;50(1):19–23. Online Ahead of Print Bazaliński D, Przybek-Mita J, Barańska B, Więch P. Marjolin’s ulcer in chronic wounds: review of available literature. Contemp Oncol. 2017 Sep;21(3):197–202. Article / Publication Details

First-Page Preview

Received: November 15, 2022
Accepted: January 22, 2023
Published online: February 15, 2023

Number of Print Pages: 3
Number of Figures: 1
Number of Tables: 0

ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)

For additional information: https://www.karger.com/SAD

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.